TickerFacts.

Company research / IOSP

Innospec Inc. (IOSP)

Build a valuation ↗↓ Download CSV

SEC name INNOSPEC INC. · CIK 0001054905 · Nasdaq · Chemicals & Allied Products

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Innospec Inc. reported revenue of $1.78B. Revenue fell 3.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.84B.

Key ratios (year ended 2025-12-31)

27.7%
Gross margin
7.3%
Operating margin
6.6%
Net margin
8.8%
Return on year-end equity
-3.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-05

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$1.84B$1.78B$1.85B$1.95B$1.96B$1.48B$1.19B$1.51B$1.48B$1.31B$883.40M
Cost of Revenue$1.34B$1.29B$1.30B$1.36B$1.38B$1.05B$850.40M$1.05B$1.04B$903.50M$551.10M
Gross Profit$505.90M$492.40M$542.90M$591.10M$586.70M$434.90M$342.70M$466.20M$435.00M$403.30M$332.30M
R&D Expense$52.10M$51.00M$56.50M$49.00M$38.70M$37.40M$30.90M$35.40M$33.40M$31.40M$25.40M
Operating Income$128.90M$129.50M$177.90M$161.60M$187.30M$132.10M$33.70M$149.90M$133.50M$125.00M$98.20M
Depreciation & Amortization$41.50M$43.60M$43.50M$39.30M$40.10M$42.70M$46.00M$47.60M$49.60M$50.40M$38.10M
EBITDA$170.40M$173.10M$221.40M$200.90M$227.40M$174.80M$79.70M$197.50M$183.10M$175.40M$136.30M
Net Incomen/a$116.60M$35.60M$139.10M$133.00M$93.10M$28.70M$112.20M$85.00M$61.80M$81.30M
EPS (Diluted)n/a$4.67$1.42$5.56$5.32$3.75$1.16$4.54$3.45$2.52$3.33
Total Assets$1.85B$1.83B$1.73B$1.71B$1.60B$1.57B$1.40B$1.47B$1.47B$1.41B$1.18B
Total Liabilities$495.20M$499.50M$518.60M$557.80M$563.30M$537.90Mn/an/an/an/an/a
Long-Term Debtn/an/an/an/an/an/a$0$58.60M$207.60M$218.40M$268.80M
Shareholders' Equity$1.34B$1.33B$1.21B$1.15B$1.04B$1.03B$944.40M$918.50M$825.00M$793.90M$653.50M
Cash & Equivalents$250.20M$292.50M$289.20M$203.70M$147.10M$141.80M$105.30M$75.70M$123.10M$90.20M$101.90M
Operating Cash Flown/a$138.30M$184.50M$207.30M$81.70M$93.20M$145.90M$161.60M$104.90M$82.70M$105.50M
Share Repurchases$24.10M$23.90M$700.0K$1.10M$5.90M$800.0K$2.10M$2.40M$1.40M$1.10M$8.40M
Dividends Paid$44.30M$42.40M$38.80M$35.10M$31.70M$28.80M$25.60M$25.00M$21.70M$18.60M$15.90M
Dividends Per Sharen/a$1.71$1.55$1.41$1.28$1.16$1.04$1.02$0.89$0.77$0.67
Weighted Average Diluted Sharesn/a24.99M25.12M25.02M24.98M24.85M24.78M24.73M24.60M24.49M24.44M
EPS (Basic)n/a$4.69$1.43$5.60$5.37$3.78$1.17$4.58$3.48$2.56$3.39

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView